17 High Momentum Healthcare Dividend Stocks

Healthcare dividend stocks with highest beta ratios originally published at long-term-investments.blogspot.com. You know that I am a conservative investor and try to minimize my risk.

This strategy is necessary if you have a larger amount of money to take care of or you begin to cry when you lose 10 percent on your book value. The second disadvantage is that you lose performance in a strong up moving market. 

Since 2009, there were nearly no bigger corrections at the market but with low beta and safe haven stocks, your performance would be only half of the return from the markets. What you need to get a push for your portfolio is a high beta stock. I don’t recommend buying them because it’s a definitely riskier strategy and nobody knows when the market turns into a bearish mood.

However, let’s take a look at the high fly momentum stocks from the healthcare sector. Those are stocks with the highest beta ratio from the sector. They have a beta between 1 and 2. With focus on the dividend paying stocks, only 17 stocks from the healthcare sector pay a dividend and being correlated with the market by a factor of up to 2.

One High-Yield is below the results and 16 have a current buy or better rating by brokerage firms.

Half-Time Report: The Best Healthcare Dividend Stocks And Which Of Them Are The Cheapest

Healthcare dividend stocks with the highest year-to-date performance originally published at "long-term-investments.blogspot.com". We’ve completed the month June and it’s time to report which stocks have risen most within the first six months of the year. It’s ever good to see which stocks are hot in the market and which of them are still cheap valuated.

That’s the main reason why I like to produce an article serial with performance figures of the best performing stocks from several sectors of the financial market.

Today I like to screen the healthcare sector by dividend stocks with the highest stock performance since the beginning of the year.

The 20 most successful companies have realized a performance between 22.01 percent and 73.98 percent. The average capital gain was 36.24 percent. Despite the strong stock price hike, seventeen of them still have a buy or better rating.

13 Highly Shorted Healthcare Dividend Stocks

Healthcare dividend stocks with the highest float short ratio originally published at "long-term-investments.blogspot.com". Selling a stock short is a popular method by investors to make a capital gain in a falling market. If investors believe that the stock price should fall, they borrow shares of the company and sell them on the market in order to hope that the stock price falls much more and that he can buy back the borrowed shares for a cheaper price.

Activists often sell stocks short. They try to scary other investors. Today I like to show you which of the healthcare stocks have the highest float short ratio. The ratio shows you how many shares have been sold short. It’s ever interesting to see which companies have some problems and investors like to speculate on a falling stock price. The higher the ratio is, the bigger the problems of the company.

These are my criteria:

- Positive Dividend Yield

- Healthcare Sector Relationship

- Float Short Ratio over 5 percent

Thirteen healthcare dividend stocks have fulfilled these criteria. Eight of them have a current buy or better rating.

20 Cheapest Healthcare Dividend Stocks

Healthcare dividend stocks with low forward P/E ratios originally published at "long-term-investments.blogspot.com". Wow, the stock market rises from month to month. The negative thing is that stock prices rise faster than the earnings and stocks getting therefore more expensive. This is a development which is still healthy because of the low yielding bond market. But it’s not sustainable if the interest rates rise. Everybody can imagine what happens if the Fed hikes its rates.

So, my major screening focus goes to cheap stocks, stocks with a low price to earnings ratio. Below is a list of the 20 cheapest healthcare dividend stocks with a forward P/E of less than 15. Health care plans companies are currently the cheapest choice in the list. Two High-Yields are part of the results and fifteen companies are recommended to buy.

GlaxoSmithKline: Dividend Stock Buy For The Dividend Yield Passive Income Portfolio

The British drug manufacturer GlaxoSmithKline is the next stock purchase for my Dividend Yield Passive Income Portfolio (DYPI). I bought 30 shares at $52.16, the ADR version of the British stock. 

The total purchase amount was $1,569.80 and represents roughly 1.5 percent of the full portfolio value.

Dividend Yield Passive Income Portfolio (Click to enlarge)

Latest Portfolio Transactions (Click to enlarge)

GlaxoSmithKline discovers, develops, manufactures, and markets pharmaceutical products, over-the-counter medicines, and health-related consumer products worldwide. It offers pharmaceutical products in various therapeutic areas comprising respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, antibacterials, oncology and emesis, dermatology, rare diseases, immuno-inflammation, vaccines, and HIV. The company provides prescription medicines to treat a range of conditions, including infections, depression, skin conditions, asthma, heart and circulatory disease, and cancer.

GSK is one of the world’s leading drug manufactures with a solid non pharmaceutical division. It sells also oral care products and is the second biggest global player behind Colgate. The current dividend yield is above the 5 percent mark at 5.29 percent and the price to earnings ratio amounts to 18.90. The stock started to gain more momentum which resulted in a year to date gain of 21.81 percent.

Earnings and Dividends From GlaxoSmithKline GSK

The new GSK stake gives me $70.35 dividend income. The full portfolio dividend income is now estimated at $1,405.61. I plan to increase the total number of stocks by the end of the year to 50-70. As a result, the dividend income should grew to $3,000 to 4,000.

All I need to do is to hunt further for stocks with a yield over 3 percent. As of now, the acquisition process was successful done with a yield on cost of 3.26%.

The DYPI-Portfolio was funded virtual on October 04, 2012 with 100k. Each week, I try to put one stock into the portfolio with a solid dividend growth history as well as an attractive yield. It’s a slow buying process but in line with my strategy to show you how long-term dividend investing works.

Not all stocks will deliver a great performance over the time but I believe that the huge amount of stockholdings should result in an adequate annual return of at least 8 percent of which 3 percent are dividends.

Because of the slow purchase process and the high cash amount, the full portfolio performance is up 4 percent since the date of funding. A deeper look at the stockholdings shows that the core performance is at 8.46 percent, a value better than the Dow Jones, Nasdaq and S&P 500.

Portfolio Performance (Click to enlarge)

Here is the income perspective of the portfolio:

Sym	Name	P/E Ratio	Dividend Yield		Buy	# Shrs	Income	Value
TRI	Thomson Reuters C	13.3	3.88		28.90	50	$64.25	$1,659.00
LMT	Lockheed Martin C	11.35	4.38		92.72	20	$86.00	$1,979.40
INTC	Intel Corporation	11.68	3.79		21.27	50	$44.25	$1,170.00
MCD	McDonald's Corpor	18.72	2.91		87.33	15	$44.10	$1,513.35
WU	Western Union Com	8.69	3.07		11.95	100	$45.00	$1,458.00
PM	Philip Morris Int	18.2	3.55		85.42	20	$67.18	$1,906.20
JNJ	Johnson & Johnson	23.15	2.86		69.19	20	$48.80	$1,702.40
MO	Altria Group Inc	17.46	4.81		33.48	40	$69.20	$1,442.80
SYY	Sysco Corporation	19.15	3.16		31.65	40	$44.00	$1,392.00
DRI	Darden Restaurant	15.54	3.92		46.66	30	$60.00	$1,529.70
CA	CA Inc.	13.23	3.84		21.86	50	$50.00	$1,299.00
PG	Procter & Gamble	17.38	2.99		68.72	25	$57.20	$1,927.50
KRFT	Kraft Foods Group	18.65	3.93		44.41	40	$80.00	$2,036.80
MAT	Mattel Inc.	19.46	2.88		36.45	40	$51.60	$1,786.00
PEP	Pepsico Inc. Com	21.22	2.6		70.88	20	$43.00	$1,650.20
KMB	Kimberly-Clark Co	22.51	2.93		86.82	15	$45.45	$1,546.80
COP	ConocoPhillips Co	8.68	4.48		61.06	20	$52.80	$1,178.20
GIS	General Mills In	18.09	2.67		42.13	30	$39.60	$1,490.40
UL	Unilever PLC Comm	21.3	2.95		39.65	35	$43.89	$1,493.80
NSRGY	NESTLE SA REG SHR	19.69	3.11		68.69	30	$65.31	$2,094.84
GE	General Electric	16.26	3.28		23.39	65	$46.80	$1,443.65
ADP	Automatic Data Pr	23.29	2.49		61.65	25	$41.50	$1,664.75
K	Kellogg Company C	24.64	2.66		61.52	25	$43.75	$1,642.50
KO	Coca-Cola Company	22.16	2.47		38.83	40	$41.80	$1,684.00
RTN	Raytheon Company	10.7	3.46		57.04	20	$41.00	$1,204.00
RCI	Rogers Communicat	14.72	3.32		51.06	30	$48.69	$1,479.60
GPC	Genuine Parts Com	18.24	2.68		77.06	20	$40.44	$1,500.80
TSCDY	TESCO PLC SPONS A	230	4.11		17.98	70	$49.63	$1,227.45
APD	Air Products and	15.4	3.06		85.71	15	$39.45	$1,283.85
GSK	GlaxoSmithKline P	18.93	5.29		52.16	30	$70.35	$1,564.80
							$1,405.61	$42,875.69
							Average Yield	3.28%
							Yield On Cost	3.26%